pharmaphorum
AUGUST 10, 2020
Swiss medical data specialist Sophia Genetics has launched a platform that will sift through data generated at more than 1,000 hospitals around the world to try to work out how the COVID-19 pandemic will evolve in the coming months and years. The evolution of the disease must be predicted in order to create containment measures,” he added. “We
pharmaphorum
MAY 4, 2022
There are existing alternatives, with one being human cell culture systems, which provide an environment that is closer to that which will eventually receive treatment but do not contain the complexity of a complete organism. Organ-on-a-chip.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
AUGUST 23, 2021
The vaccine may be a latecomer to the COVID-19 vaccine arsenal, but its approval signals the potential of DNA vaccines and is a boost to companies working in this space. The company also says that it can update the vaccine very easily to deal with mutations in the virus.
pharmaphorum
APRIL 26, 2022
The microbiome, as a term, can be related to the nasal, oral, skin, gastro-intestinal, and urogenital regions of the human body, each containing varied microbial communities that have an impact on health. The possibilities.
XTalks
DECEMBER 20, 2023
Novo Nordisk’s GLP-1 weight loss-specific drug Wegovy (semaglutide) has been facing similar shortages, as it contains the same active ingredient as Ozempic. Check out this article to learn about the biotech companies that went public this year.
pharmaphorum
SEPTEMBER 18, 2020
But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.
Drug Discovery World
DECEMBER 14, 2023
The university contains the Medical Research Council (MRC)-University of Glasgow Centre for Virus Research (CVR), as well as CRUSH, part of CVR and established in partnership with LifeArc to address pandemic preparedness. For a growing company like BioAscent, there are huge advantages in being situated within a cluster.
Expert insights. Personalized for you.
136 
Let's personalize your content